Results 121 to 130 of about 1,786 (140)

Vulvovaginal Collagen Injection as a Regenerative Strategy in Genitourinary Syndrome of Menopause: Results of a Pilot Study. [PDF]

J Clin Med
Borobia Pérez AI, Estévez Espejo JJ, Jiménez-González M, García López RD.   +3 more
europepmc   +1 more source

Case Report: Giant vulvar ulcer caused by Behcet's disease. [PDF]

Front Med (Lausanne)
Li X, Zheng X, Wang Y, Chen Y, Chen M, You H, Wang W.   +6 more
europepmc   +1 more source

French multicentre randomised phase III trial evaluating the efficacy and safety of vaginal radiofrequency in the management of vulvovaginal atrophy and dryness in patients treated for breast cancer (RF-Vaginale): trial protocol. [PDF]

BMJ Open
Demetz J, Vanseymortier M, Martin C, Ben Oune F, Alloy N, Leguillette C, Penel N, Chauvet MP, Le Deley MC.   +8 more
europepmc   +1 more source

Gynecoplastic Surgery: A Unified Terminology for Female Genital Aesthetic, Reconstructive, and Functional Procedures. [PDF]

Cureus
Togo JM, Hurtado TM, Gonzalez P.
europepmc   +1 more source

Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy [PDF]

Climacteric, 2017
In the absence of a direct head-to-head study, we performed an indirect historical comparison of ospemifene 60 mg (Senshio®) vs. local vaginal estrogens in moderate or severe vulvar and vaginal atrophy (VVA).
Marco Anelli, Santiago Palacios, A O Mueck   +2 more
exaly   +2 more sources

The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate

Journal of Sexual Medicine, 2017
Introduction Postmenopausal women's knowledge about vulvar and vaginal atrophy (VVA) and available treatment options has historically been inadequate.
Sheryl A Kingsberg, Brian Bernick, Michael Krychman   +2 more
exaly   +2 more sources

The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment

Journal of Sexual Medicine, 2017
Introduction Vulvar and vaginal atrophy (VVA) affects up to two thirds of postmenopausal women, but most symptomatic women do not receive prescription therapy.
Sheryl A Kingsberg, Brian Bernick, Michael Krychman   +2 more
exaly   +2 more sources

Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data [PDF]

Gynecological Endocrinology, 2017
Italian participants in the European REVIVE survey reported that vaginal and vulvar atrophy (VVA) impaired various aspects of their lives, notably the ability to enjoy sex.
Anna Maria Paoletti, Marco Anelli, Stefano LUISI   +2 more
exaly   +2 more sources

Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey

Maturitas, 2016
Objectives To achieve a deeper understanding of the attitudes and perceptions of Italian post-menopausal women (PMW) regarding vulvo-vaginal atrophy (VVA).
Anna Maria Paoletti, Marco Anelli, Stefano LUISI   +2 more
exaly   +2 more sources